Participants on the placebo lost an average of 6% of their weight
Post-discontinuation, 19.6 % restarted the original medication, while 35 % adopted another option: alternative medication (27.4 %), healthcare visit for lifestyle modification (13.7 %), and metabolic and bariatric surgery (0.6 %)
While Ozempic is FDA-approved specifically for type 2 diabetes and related cardiovascular and kidney conditions, some healthcare providers may prescribe it for other uses based on their professional medical judgment and your individual health circumstances
It is generally mild and self-limiting rather than a sign that anything went wrong
Therefore, increasing prevalence of type 2 diabetes and obesity is one of the significant factors driving the the Glucagon-like Peptide 1 (GLP-1) market growth in the forecast period
What insulin resistance feels like As oestrogen declines, cells throughout the body become less responsive to insulin